Edge Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Edge Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.6M	Buy	111,283 +148	+0.1%	+$20K	2.97%	13
2026 Q1	$14.2M	Buy	111,135 +1,104	+1%	+$138K	2.43%	17
2025 Q4	$13.4M	Sell	110,031 -2,280	-2%	-$261K	2.37%	15
2025 Q3	$11.3M	Buy	112,311 +384	+0.3%	+$34.6K	1.99%	19
2025 Q2	$9.28M	Buy	111,927 +1,459	+1%	+$116K	1.79%	23
2025 Q1	$8.96M	Buy	110,468 +2,791	+3%	+$249K	1.82%	23
2024 Q4	$9.7M	Sell	107,677 -1,959	-2%	-$190K	1.96%	20
2024 Q3	$10.8M	Sell	109,636 -274	-0.2%	-$26.9K	2.17%	20
2024 Q2	$10.2M	Sell	109,910 -1,929	-2%	-$173K	2.15%	19
2024 Q1	$10.6M	Sell	111,839 -568	-0.5%	-$52.7K	2.23%	19
2023 Q4	$10M	Buy	112,407 +256	+0.2%	+$19K	2.19%	19
2023 Q3	$8.19M	Sell	112,151 -1,840	-2%	-$147K	1.91%	21
2023 Q2	$9.48M	Buy	113,991 +3,448	+3%	+$288K	2.07%	20
2023 Q1	$8.4M	Buy	110,543 +816	+0.7%	+$67.7K	1.93%	21
2022 Q4	$8.93M	Sell	109,727 -15,598	-12%	-$1.26M	2.08%	21
2022 Q3	$10.1M	Buy	125,325 +3,214	+3%	+$271K	2.24%	19
2022 Q2	$9.07M	Sell	122,111 -2,970	-2%	-$223K	1.96%	20
2022 Q1	$11.2M	Buy	125,081 +4,127	+3%	+$381K	2.21%	19
2021 Q4	$13.5M	Buy	120,954 +120,405	+21,932%	+$14.5M	2.48%	15
2021 Q3	$69K	Buy	549 +495	+917%	+$63.7K	0.01%	162
2021 Q2	$7K	Hold	54	–	–	﹤0.01%	331
2021 Q1	$7K	Hold	54	–	–	﹤0.01%	320
2020 Q4	$8K	Sell	54 -69	-56%	-$8.84K	﹤0.01%	283
2020 Q3	$14K	Sell	123 -9,964	-99%	-$1.12M	﹤0.01%	299
2020 Q2	$1.13M	Sell	10,087 -2,252	-18%	-$222K	0.21%	63
2020 Q1	$953K	Sell	12,339 -1,349	-10%	-$119K	0.21%	63
2019 Q4	$1.3M	Sell	13,688 -224	-2%	-$19.4K	0.26%	61
2019 Q3	$1.06M	Buy	13,912 +33	+0.2%	+$2.74K	0.24%	65
2019 Q2	$1.22M	Buy	13,879 +16	+0.1%	+$1.36K	0.27%	58
2019 Q1	$1.26M	Sell	13,863 -979	-7%	-$83.3K	0.31%	56
2018 Q4	$1.06M	Buy	14,842 +14,622	+6,646%	+$1.18M	0.3%	53
2018 Q3	$21K	Sell	220 -230	-51%	-$22.3K	0.01%	365
2018 Q2	$43K	Sell	450 -595	-57%	-$54.7K	0.01%	262
2018 Q1	$92K	Buy	1,045 +946	+956%	+$86.4K	0.02%	169
2017 Q4	$8K	Hold	99	–	–	﹤0.01%	406
2017 Q3	$9K	Hold	99	–	–	﹤0.01%	391
2017 Q2	$8K	Hold	99	–	–	﹤0.01%	397
2017 Q1	$7K	Hold	99	–	–	﹤0.01%	389
2016 Q4	$6K	Hold	99	–	–	﹤0.01%	387
2016 Q3	$7K	Hold	99	–	–	﹤0.01%	373
2016 Q2	$5K	Hold	99	–	–	﹤0.01%	372
2016 Q1	$5K	Hold	99	–	–	﹤0.01%	345
2015 Q4	$7K	Buy	+99	New	+$6.75K	﹤0.01%	326

Other funds holding XBI

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

PSP Research Newtown Square, Pennsylvania $188M AUM

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

MFS

Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return

LHWM

Lake Hills Wealth Management Austin, Texas $220M AUM 39.11% 1-Year Est. Return

MWA

MFA Wealth Advisors Pittsburgh, Pennsylvania $587M AUM 27.44% 1-Year Est. Return

Parkside Investments Deerfield, Illinois $902M AUM 32.45% 1-Year Est. Return

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

MAM

Marotta Asset Management Charlottesville, Virginia $601M AUM 21.35% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Edge Wealth Management's XBI Position: Q2 2026 in Review

Edge Wealth Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 0.13% in Q2 2026, buying an estimated $20K and bringing the position to 111,283 shares worth $17.6M. The position accounts for 2.97% of the portfolio, ranked #13.

Edge Wealth Management first reported a position in XBI in Q4 2015 and has held it in 43 quarters since. 131 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Edge Wealth Management held 111,283 shares of State Street SPDR S&P Biotech ETF worth $17.6M as of Q2 2026.
Edge Wealth Management bought 148 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $20K.
State Street SPDR S&P Biotech ETF made up 2.97% of Edge Wealth Management's portfolio in Q2 2026, its #13 holding.
Edge Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2015 and has held it in 43 quarters since.
131 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Edge Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.